Stay updated on AD Up Clinical Trial
Sign up to get notified when there's something new on the AD Up Clinical Trial page.

Latest updates to the AD Up Clinical Trial page
- Check2 days agoChange DetectedRevision: v3.4.1 was added and Revision: v3.4.0 was removed.SummaryDifference0.0%

- Check8 days agoNo Change Detected
- Check16 days agoChange DetectedAdded a glossary toggle and new metadata fields (Last Update Submitted that Met QC Criteria, Last Update Posted, No FEAR Act Data, Revision: v3.4.0) and removed the older labels (Last Update Submitted that met QC Criteria, Last Update Posted (Estimated), No FEAR Act data, Revision: v3.3.4).SummaryDifference0.1%

- Check23 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4 on the page header; this is a minor metadata change and does not affect the study content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check44 days agoChange DetectedRecruitment status changed from Enrolling by invitation to Active, not recruiting. Enrollment updated from Estimated 1500 to Actual 1533 with the latest update posted on 2025-12-23.SummaryDifference0.1%

- Check51 days agoChange DetectedAdded a comprehensive, country/region–organized list of study locations worldwide (spanning US states, Australia regions, European regions, and other countries) and removed the previous consolidated location groupings.SummaryDifference3%

- Check65 days agoChange DetectedAdded a 2025 publication reference for the Upadacitinib AD trial (Irvine et al., Am J Clin Dermatol 2025) in the Publications section. Removed the previous Online ahead of print citation for the same article.SummaryDifference0.0%

Stay in the know with updates to AD Up Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AD Up Clinical Trial page.